Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Fahlenkamp

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Journal of Urology|April 18, 2007
Laparoscopic treatment of urachal remnants in childrenSalmai Turial, Thomas Hueckstaedt, Felix Schier, et al.
Oncotargets and Therapy|February 19, 2016
Tumor heterogeneity as a rationale for a multi-epitope approach in an autologous renal cell cancer tumor vaccineStefan Wittke, Susann Baxmann, Dirk Fahlenkamp, et al.
The Journal of Urology|September 18, 2007
Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patientsMatthias May, Nina Knoll, Michael Siegsmund, et al.
Urology|February 19, 2017
Delayed Radiographic Manifestation of Renal Pseudoaneurysms After Blunt TraumaMichael Froehner, Felix Schaab, Thomas Hofmockel, et al.
Urologic Nursing|January 26, 2008
Radical retropubic vs. radical perineal prostatectomy: a comparison of relative benefits in four urban hospitalsMatthias May, Manuela Dorst, Jana May, et al.
The Journal of Urology|February 22, 2011
Urolithiasis through the ages: data on more than 200,000 urinary stone analysesThomas Knoll, Anne B Schubert, Dirk Fahlenkamp, et al.
Advanced Drug Delivery Reviews|December 3, 2014
Regulatory challenges for autologous tissue engineered products on their way from bench to bedside in EuropeGouya Ram-Liebig, Juergen Bednarz, Burkard Stuerzebecher, et al.
Lancet (London, England)|February 28, 2004
Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trialDieter Jocham, Axel Richter, Lothar Hoffmann, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 15, 2014
Cancer-related fatigue in patients before and after radical prostatectomy. Results of a prospective multi-centre studyNorbert Köhler, Lutz Gansera, Sigrun Holze, et al.
The Journal of Urology|March 31, 2018
Anterior Urethroplasty Using a New Tissue Engineered Oral Mucosa Graft: Surgical Techniques and OutcomesGuido Barbagli, Ilgar Akbarov, Axel Heidenreich, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Journal of Urology|April 18, 2007
Laparoscopic treatment of urachal remnants in childrenSalmai Turial, Thomas Hueckstaedt, Felix Schier, et al.
Oncotargets and Therapy|February 19, 2016
Tumor heterogeneity as a rationale for a multi-epitope approach in an autologous renal cell cancer tumor vaccineStefan Wittke, Susann Baxmann, Dirk Fahlenkamp, et al.
The Journal of Urology|September 18, 2007
Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patientsMatthias May, Nina Knoll, Michael Siegsmund, et al.
Urology|February 19, 2017
Delayed Radiographic Manifestation of Renal Pseudoaneurysms After Blunt TraumaMichael Froehner, Felix Schaab, Thomas Hofmockel, et al.
Urologic Nursing|January 26, 2008
Radical retropubic vs. radical perineal prostatectomy: a comparison of relative benefits in four urban hospitalsMatthias May, Manuela Dorst, Jana May, et al.
The Journal of Urology|February 22, 2011
Urolithiasis through the ages: data on more than 200,000 urinary stone analysesThomas Knoll, Anne B Schubert, Dirk Fahlenkamp, et al.
Advanced Drug Delivery Reviews|December 3, 2014
Regulatory challenges for autologous tissue engineered products on their way from bench to bedside in EuropeGouya Ram-Liebig, Juergen Bednarz, Burkard Stuerzebecher, et al.
Lancet (London, England)|February 28, 2004
Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trialDieter Jocham, Axel Richter, Lothar Hoffmann, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 15, 2014
Cancer-related fatigue in patients before and after radical prostatectomy. Results of a prospective multi-centre studyNorbert Köhler, Lutz Gansera, Sigrun Holze, et al.
The Journal of Urology|March 31, 2018
Anterior Urethroplasty Using a New Tissue Engineered Oral Mucosa Graft: Surgical Techniques and OutcomesGuido Barbagli, Ilgar Akbarov, Axel Heidenreich, et al.
Pageof 2